New pill aims to stop migraine pain in 2 hours
NCT ID NCT04163185
Summary
This study tested whether a single dose of a new oral medication called AXS-07 could stop migraine pain and the most bothersome symptom within two hours. It involved 302 adults with migraines who were randomly assigned to receive either the medication or a placebo pill when a migraine started. The goal was to see if AXS-07 was more effective and safe than a placebo for acute migraine relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Birmingham, Alabama, 35205, United States
-
Clinical Research Site
Birmingham, Alabama, 35216, United States
-
Clinical Research Site
Mobile, Alabama, 36608, United States
-
Clinical Research Site
Colton, California, 92399, United States
-
Clinical Research Site
Encino, California, 91316, United States
-
Clinical Research Site
Los Alamitos, California, 90720, United States
-
Clinical Research Site
Los Angeles, California, 90017, United States
-
Clinical Research Site
Redlands, California, 92374, United States
-
Clinical Research Site
Santa Monica, California, 90404, United States
-
Clinical Research Site
Spring Valley, California, 91978, United States
-
Clinical Research Site
Walnut Creek, California, 94598, United States
-
Clinical Research Site
Hallandale, Florida, 33009, United States
-
Clinical Research Site
Jacksonville, Florida, 32256, United States
-
Clinical Research Site
Lake City, Florida, 32055, United States
-
Clinical Research Site
Lake Worth, Florida, 33467, United States
-
Clinical Research Site
Ocoee, Florida, 34761, United States
-
Clinical Research Site
Orlando, Florida, 32801, United States
-
Clinical Research Site
Ormond Beach, Florida, 32174, United States
-
Clinical Research Site
South Miami, Florida, 33143, United States
-
Clinical Research Site
Sunrise, Florida, 33351, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Stockbridge, Georgia, 30281, United States
-
Clinical Research Site
Evanston, Illinois, 60201, United States
-
Clinical Research Site
Louisville, Kentucky, 40213, United States
-
Clinical Research Site
Boston, Massachusetts, 02131, United States
-
Clinical Research Site
Waltham, Massachusetts, 02451, United States
-
Clinical Research Site
Ann Arbor, Michigan, 48104, United States
-
Clinical Research Site
Springfield, Missouri, 65810, United States
-
Clinical Research Site
Albuquerque, New Mexico, 87102, United States
-
Clinical Research Site
Manlius, New York, 13104, United States
-
Clinical Research Site
Williamsville, New York, 14221, United States
-
Clinical Research Site
High Point, North Carolina, 27262, United States
-
Clinical Research Site
Oklahoma City, Oklahoma, 73106, United States
-
Clinical Research Site
Philadelphia, Pennsylvania, 19114, United States
-
Clinical Research Site
Charleston, South Carolina, 29406, United States
-
Clinical Research Site
Mt. Pleasant, South Carolina, 29464, United States
-
Clinical Research Site
Memphis, Tennessee, 38119, United States
-
Clinical Research Site
Nashville, Tennessee, 37203, United States
-
Clinical Research Site
Austin, Texas, 78731, United States
-
Clinical Research Site
Salt Lake City, Utah, 84107, United States
-
Clinical Research Site
Charlottesville, Virginia, 22911, United States
Conditions
Explore the condition pages connected to this study.